Use Of Esomeprazole In Postoperative Bariatric Surgery Patients Users And Non-Users Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
NCT00608712 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 140
Last updated 2011-01-24
Summary
Phase IV, open-label, multicenter, non-randomized, with 2 non-comparative investigational arms study, carried out in morbid obesity patients who had undergone gastric bypass surgery for body weight reduction
Conditions
- Postoperative Bariatric Surgery
Interventions
- DRUG
-
Esomeprazole
Esomeprazole 20mg oral tablet
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-11-30
- Primary Completion
- 2006-08-31
- Completion
- 2006-08-31
More Related Trials
-
Efficacy of Esomeprazole in Patients With Frequent Heartburn
NCT01370538 ·Status: COMPLETED ·Phase: PHASE3
-
Proton Pump Inhibitors Effects on Dyspepsia During Ramadan Fasting
NCT05287633 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis.
NCT00206284 ·Status: COMPLETED ·Phase: PHASE2
-
Barrett's Esophagus - 315 - 3 Way Cross-Over
NCT00637559 ·Status: COMPLETED ·Phase: PHASE4
-
Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients
NCT00222131 ·Status: COMPLETED ·Phase: PHASE2
-
The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass
NCT05320796 ·Status: RECRUITING ·Phase: PHASE4
-
Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)
NCT00625495 ·Status: COMPLETED ·Phase: PHASE4
-
Esomeprazole (NEXIUM) vs. Surgery
NCT00251927 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)
NCT00626535 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer
NCT00595517 ·Status: COMPLETED ·Phase: PHASE3
-
Barrett's Esophagus - 315 - 3 Way Cross Over
NCT00637988 ·Status: COMPLETED ·Phase: PHASE4
-
Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed Esophagitis
NCT00586963 ·Status: COMPLETED
-
Bioequivalence Study of Esomeprazole in Healthy Adult Subjects Under Fasting Condition
NCT05235217 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Esomeprazole in Patients With Frequent Heartburn
NCT01370525 ·Status: COMPLETED ·Phase: PHASE3
-
APE-Study: Ablation of Barrett's Mucosa vs. Surveillance Without Ablation in Patients Cured From Barrett's Cancer Combined With Randomization of Esomeprazole vs. Placebo for Symptomatic Reflux Control After Successful Barrett's Ablation
NCT00546065 ·Status: TERMINATED ·Phase: NA
-
AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers
NCT00325715 ·Status: COMPLETED ·Phase: PHASE1
-
Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients
NCT01119768 ·Status: COMPLETED ·Phase: PHASE4
-
Stress Ulcer Prophylaxis of Intravenous Esomeprazole in Chinese Seriously Ill Patients
NCT02157376 ·Status: COMPLETED ·Phase: PHASE3
-
Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs
NCT00241514 ·Status: COMPLETED ·Phase: PHASE3
-
Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs
NCT00241540 ·Status: COMPLETED ·Phase: PHASE3
-
Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?
NCT01093755 ·Status: COMPLETED ·Phase: PHASE4
-
An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)
NCT00629564 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Baricitinib and Omeprazole in Healthy Participants
NCT01925144 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Effect of JNJ-67953964 on Gastric Mucosal Integrity in Healthy Male and Female Participants
NCT04185051 ·Status: COMPLETED ·Phase: PHASE1
-
The ESG Integrity Study: Effect of Proton Pump Inhibitors on the Structural Integrity of Endoscopic Sleeve Gastroplasty
NCT06283381 ·Status: RECRUITING ·Phase: PHASE4